The Pediatric Early Development Symposium (PEDS) is dedicated to advancing pediatric cancer drug development through pharmacokinetics, modeling, and improved clinical trial designs.
Topics
- How Pharmacokinetics can Enhance the Design of Your Clinical Trial
- Overview of Concepts and Terminology of Pharmacokinetics
- What are critical elements and practical expectations for the FDA
- Dose-Response Relationship: Step from Animals to Humans Fundamentally Flawed?
- How to/Who Identifies the Minimum Number of Patients Needed in a Trial?
- How do you Operationalize a Trial in the Pediatric Population?
- Keynote: Designing Data with a Focus on Pharmacokinetics and Clinical Trials
- How to Bring a Therapeutic Agent to the Clinic for Kids with Cancer Using Data?
- Breakout Sessions – How Can We Break Down Barriers and Better Solve Problems in Clinical Trials?
- Appropriate Use of Extrapolation and Modeling Data from Adults
- AI/ML: The True Future of Drug Development in Pediatric Oncology
- Advanced Modeling Techniques Enhance Future Drug Development
- Future of Clinical Trials in Children with Cancer: We Must Do Better
Who should Attend
Attendees involved or interested in:
- Clinical Operations
- Late Development
- Academic
- Management/Executives
- Patient Advocates
- Key Opinion Leaders
- Medical Affairs
- Regulators
- Project Management
- Clinical Affairs
- Research and Development
- Regulatory Affairs
- Early Development
